Download | < Back |
29 May 2015 | |
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated May 29, 2015 titled "Dr Reddy's Laboratories Limited and AstraZeneca Pharma India Limited entered into a distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes". | |
View all announcements for DR.REDDY'S LABORATORIES LTD. | Source: BSE India |